APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical AI Data Analysis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical AI Data Analysis Market Outlook and Growth Opportunities 2026

15 January 2026213 pages

Choose your research edition.

Industry ResearchMedical AI Data Analysis Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical AI Data Analysis Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Medical AI Data Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical AI Data Analysis Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical AI Data Analysis Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Medical AI Data Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical AI Data Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical AI Data Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical AI Data Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical AI Data Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical AI Data Analysis market include Tempus, PathAI, Paige AI, Aidoc, Viz.ai, RapidAI, Enlitic, Nanox AI and Lunit, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical AI Data Analysis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical AI Data Analysis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical AI Data Analysis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical AI Data Analysis market.

Medical AI Data Analysis Segment by Company

Tempus

PathAI

Paige AI

Aidoc

Viz.ai

RapidAI

Enlitic

Nanox AI

Lunit

Subtle Medical

Volpara Health

icometrix

Niramai

Densitas

RetinAI

Riverain Technologies

Digital Diagnostics

ANNALISE.ai

Imagen Technologies

Ultromics

Us2.ai

UltraSight

Notal Vision

iCAD

Medicsight

Delft Imaging

INFERVISION

YITU Healthcare

Shukun Technology

Keya Medical

BioMind

United Imaging

Merative

GE HealthCare

Siemens Healthineers

Medical AI Data Analysis Segment by Type

On-device / Embedded AI Solutions

Hybrid Edge–Cloud AI Platforms

Others

Medical AI Data Analysis Segment by Application

Hospital

Drug Research

Nursing

Other

Medical AI Data Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical AI Data Analysis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical AI Data Analysis key companies, revenue, market share, and recent developments.

3. To split the Medical AI Data Analysis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical AI Data Analysis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical AI Data Analysis significant trends, drivers, influence factors in global and regions.

6. To analyze Medical AI Data Analysis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical AI Data Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical AI Data Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical AI Data Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical AI Data Analysis industry.

Chapter 3: Detailed analysis of Medical AI Data Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical AI Data Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical AI Data Analysis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical AI Data Analysis Industry Trends Table 2. Medical AI Data Analysis Industry Drivers Table 3. Medical AI Data Analysis Industry Opportunities and Challenges Table 4. Medical AI Data Analysis Industry Restraints Table 5. Global Medical AI Data Analysis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical AI Data Analysis Revenue Share by Company (2021-2026) Table 7. Global Medical AI Data Analysis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical AI Data Analysis Key Company Manufacturing Base & Headquarters Table 9. Global Medical AI Data Analysis Company, Product Type & Application Table 10. Global Medical AI Data Analysis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical AI Data Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of On-device / Embedded AI Solutions Table 15. Significant Companies of Hybrid Edge–Cloud AI Platforms Table 16. Significant Companies of Others Table 17. Global Medical AI Data Analysis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Medical AI Data Analysis Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Medical AI Data Analysis Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Medical AI Data Analysis Sales Value Share by Type (2021-2026) Table 21. Global Medical AI Data Analysis Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospital Table 23. Significant Companies of Drug Research Table 24. Significant Companies of Nursing Table 25. Significant Companies of Other Table 26. Global Medical AI Data Analysis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical AI Data Analysis Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Medical AI Data Analysis Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Medical AI Data Analysis Sales Value Share by Application (2021-2026) Table 30. Global Medical AI Data Analysis Sales Value Share by Application (2027-2032) Table 31. Global Medical AI Data Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Medical AI Data Analysis Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Medical AI Data Analysis Sales Value Share by Region (2021-2026) Table 34. Global Medical AI Data Analysis Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Medical AI Data Analysis Sales Value Share by Region (2027-2032) Table 36. Global Medical AI Data Analysis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Medical AI Data Analysis Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Medical AI Data Analysis Sales Value Market Share by Country (2021-2026) Table 39. Global Medical AI Data Analysis Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Medical AI Data Analysis Sales Value Market Share by Country (2027-2032) Table 41. Tempus Company Information Table 42. Tempus Business Overview Table 43. Tempus Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Tempus Medical AI Data Analysis Product Portfolio Table 45. Tempus Recent Development Table 46. PathAI Company Information Table 47. PathAI Business Overview Table 48. PathAI Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. PathAI Medical AI Data Analysis Product Portfolio Table 50. PathAI Recent Development Table 51. Paige AI Company Information Table 52. Paige AI Business Overview Table 53. Paige AI Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Paige AI Medical AI Data Analysis Product Portfolio Table 55. Paige AI Recent Development Table 56. Aidoc Company Information Table 57. Aidoc Business Overview Table 58. Aidoc Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Aidoc Medical AI Data Analysis Product Portfolio Table 60. Aidoc Recent Development Table 61. Viz.ai Company Information Table 62. Viz.ai Business Overview Table 63. Viz.ai Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Viz.ai Medical AI Data Analysis Product Portfolio Table 65. Viz.ai Recent Development Table 66. RapidAI Company Information Table 67. RapidAI Business Overview Table 68. RapidAI Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. RapidAI Medical AI Data Analysis Product Portfolio Table 70. RapidAI Recent Development Table 71. Enlitic Company Information Table 72. Enlitic Business Overview Table 73. Enlitic Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Enlitic Medical AI Data Analysis Product Portfolio Table 75. Enlitic Recent Development Table 76. Nanox AI Company Information Table 77. Nanox AI Business Overview Table 78. Nanox AI Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Nanox AI Medical AI Data Analysis Product Portfolio Table 80. Nanox AI Recent Development Table 81. Lunit Company Information Table 82. Lunit Business Overview Table 83. Lunit Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Lunit Medical AI Data Analysis Product Portfolio Table 85. Lunit Recent Development Table 86. Subtle Medical Company Information Table 87. Subtle Medical Business Overview Table 88. Subtle Medical Medical AI Data Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Subtle Medical Medical AI Data Analysis Product Portfolio Table 90. Subtle Medical Recent Development Table 91. Volpara Health Company Information Table 92. Volpara Health Business Overview Table 93. Volpara Health Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Volpara Health Medical AI Data Analysis Product Portfolio Table 95. Volpara Health Recent Development Table 96. icometrix Company Information Table 97. icometrix Business Overview Table 98. icometrix Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. icometrix Medical AI Data Analysis Product Portfolio Table 100. icometrix Recent Development Table 101. Niramai Company Information Table 102. Niramai Business Overview Table 103. Niramai Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Niramai Medical AI Data Analysis Product Portfolio Table 105. Niramai Recent Development Table 106. Densitas Company Information Table 107. Densitas Business Overview Table 108. Densitas Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Densitas Medical AI Data Analysis Product Portfolio Table 110. Densitas Recent Development Table 111. RetinAI Company Information Table 112. RetinAI Business Overview Table 113. RetinAI Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. RetinAI Medical AI Data Analysis Product Portfolio Table 115. RetinAI Recent Development Table 116. Riverain Technologies Company Information Table 117. Riverain Technologies Business Overview Table 118. Riverain Technologies Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Riverain Technologies Medical AI Data Analysis Product Portfolio Table 120. Riverain Technologies Recent Development Table 121. Digital Diagnostics Company Information Table 122. Digital Diagnostics Business Overview Table 123. Digital Diagnostics Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Digital Diagnostics Medical AI Data Analysis Product Portfolio Table 125. Digital Diagnostics Recent Development Table 126. ANNALISE.ai Company Information Table 127. ANNALISE.ai Business Overview Table 128. ANNALISE.ai Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. ANNALISE.ai Medical AI Data Analysis Product Portfolio Table 130. ANNALISE.ai Recent Development Table 131. Imagen Technologies Company Information Table 132. Imagen Technologies Business Overview Table 133. Imagen Technologies Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Imagen Technologies Medical AI Data Analysis Product Portfolio Table 135. Imagen Technologies Recent Development Table 136. Ultromics Company Information Table 137. Ultromics Business Overview Table 138. Ultromics Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Ultromics Medical AI Data Analysis Product Portfolio Table 140. Ultromics Recent Development Table 141. Us2.ai Company Information Table 142. Us2.ai Business Overview Table 143. Us2.ai Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Us2.ai Medical AI Data Analysis Product Portfolio Table 145. Us2.ai Recent Development Table 146. UltraSight Company Information Table 147. UltraSight Business Overview Table 148. UltraSight Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. UltraSight Medical AI Data Analysis Product Portfolio Table 150. UltraSight Recent Development Table 151. Notal Vision Company Information Table 152. Notal Vision Business Overview Table 153. Notal Vision Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 154. Notal Vision Medical AI Data Analysis Product Portfolio Table 155. Notal Vision Recent Development Table 156. iCAD Company Information Table 157. iCAD Business Overview Table 158. iCAD Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 159. iCAD Medical AI Data Analysis Product Portfolio Table 160. iCAD Recent Development Table 161. Medicsight Company Information Table 162. Medicsight Business Overview Table 163. Medicsight Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 164. Medicsight Medical AI Data Analysis Product Portfolio Table 165. Medicsight Recent Development Table 166. Delft Imaging Company Information Table 167. Delft Imaging Business Overview Table 168. Delft Imaging Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 169. Delft Imaging Medical AI Data Analysis Product Portfolio Table 170. Delft Imaging Recent Development Table 171. INFERVISION Company Information Table 172. INFERVISION Business Overview Table 173. INFERVISION Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 174. INFERVISION Medical AI Data Analysis Product Portfolio Table 175. INFERVISION Recent Development Table 176. YITU Healthcare Company Information Table 177. YITU Healthcare Business Overview Table 178. YITU Healthcare Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 179. YITU Healthcare Medical AI Data Analysis Product Portfolio Table 180. YITU Healthcare Recent Development Table 181. Shukun Technology Company Information Table 182. Shukun Technology Business Overview Table 183. Shukun Technology Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 184. Shukun Technology Medical AI Data Analysis Product Portfolio Table 185. Shukun Technology Recent Development Table 186. Keya Medical Company Information Table 187. Keya Medical Business Overview Table 188. Keya Medical Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 189. Keya Medical Medical AI Data Analysis Product Portfolio Table 190. Keya Medical Recent Development Table 191. BioMind Company Information Table 192. BioMind Business Overview Table 193. BioMind Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 194. BioMind Medical AI Data Analysis Product Portfolio Table 195. BioMind Recent Development Table 196. United Imaging Company Information Table 197. United Imaging Business Overview Table 198. United Imaging Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 199. United Imaging Medical AI Data Analysis Product Portfolio Table 200. United Imaging Recent Development Table 201. Merative Company Information Table 202. Merative Business Overview Table 203. Merative Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 204. Merative Medical AI Data Analysis Product Portfolio Table 205. Merative Recent Development Table 206. GE HealthCare Company Information Table 207. GE HealthCare Business Overview Table 208. GE HealthCare Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 209. GE HealthCare Medical AI Data Analysis Product Portfolio Table 210. GE HealthCare Recent Development Table 211. Siemens Healthineers Company Information Table 212. Siemens Healthineers Business Overview Table 213. Siemens Healthineers Medical AI Data Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 214. Siemens Healthineers Medical AI Data Analysis Product Portfolio Table 215. Siemens Healthineers Recent Development Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Medical AI Data Analysis Product Image Figure 2. Global Medical AI Data Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical AI Data Analysis Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical AI Data Analysis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. On-device / Embedded AI Solutions Image Figure 8. Hybrid Edge–Cloud AI Platforms Image Figure 9. Others Image Figure 10. Global Medical AI Data Analysis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Medical AI Data Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Medical AI Data Analysis Sales Value Share by Type (2021-2032) Figure 13. Hospital Image Figure 14. Drug Research Image Figure 15. Nursing Image Figure 16. Other Image Figure 17. Global Medical AI Data Analysis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Medical AI Data Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Medical AI Data Analysis Sales Value Share by Application (2021-2032) Figure 20. Global Medical AI Data Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Medical AI Data Analysis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Medical AI Data Analysis Sales Value (2021-2032) & (US$ Million) Figure 23. North America Medical AI Data Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Medical AI Data Analysis Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Medical AI Data Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Medical AI Data Analysis Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Medical AI Data Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Medical AI Data Analysis Sales Value (2021-2032) & (US$ Million) Figure 29. South America Medical AI Data Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Medical AI Data Analysis Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Medical AI Data Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Medical AI Data Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • On-device / Embedded AI Solutions
  • Hybrid Edge–Cloud AI Platforms
  • Others
Applications
  • Hospital
  • Drug Research
  • Nursing
  • Other
Companies covered
  • Tempus
  • PathAI
  • Paige AI
  • Aidoc
  • Viz.ai
  • RapidAI
  • Enlitic
  • Nanox AI
  • Lunit
  • Subtle Medical
  • Volpara Health
  • icometrix
  • Niramai
  • Densitas
  • RetinAI
  • Riverain Technologies
  • Digital Diagnostics
  • ANNALISE.ai
  • Imagen Technologies
  • Ultromics
  • Us2.ai
  • UltraSight
  • Notal Vision
  • iCAD
  • Medicsight
  • Delft Imaging
  • INFERVISION
  • YITU Healthcare
  • Shukun Technology
  • Keya Medical
  • BioMind
  • United Imaging
  • Merative
  • GE HealthCare
  • Siemens Healthineers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical AI Data Analysis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical AI Data Analysis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical AI Data Analysis Market Dynamics
  1. 2.1 Medical AI Data Analysis Industry Trends
  2. 2.2 Medical AI Data Analysis Industry Drivers
  3. 2.3 Medical AI Data Analysis Industry Opportunities and Challenges
  4. 2.4 Medical AI Data Analysis Industry Restraints
3 Medical AI Data Analysis Market by Company
  1. 3.1 Global Medical AI Data Analysis Company Revenue Ranking in 2025
  2. 3.2 Global Medical AI Data Analysis Revenue by Company (2021-2026)
  3. 3.3 Global Medical AI Data Analysis Company Ranking (2024-2026)
  4. 3.4 Global Medical AI Data Analysis Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical AI Data Analysis Company Product Type and Application
  6. 3.6 Global Medical AI Data Analysis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical AI Data Analysis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical AI Data Analysis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical AI Data Analysis Market by Type
  1. 4.1 Medical AI Data Analysis Type Introduction
  2. 4.1.1 On-device / Embedded AI Solutions
  3. 4.1.2 Hybrid Edge–Cloud AI Platforms
  4. 4.1.3 Others
  5. 4.2 Global Medical AI Data Analysis Sales Value by Type
  6. 4.2.1 Global Medical AI Data Analysis Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medical AI Data Analysis Sales Value by Type (2021-2032)
  8. 4.2.3 Global Medical AI Data Analysis Sales Value Share by Type (2021-2032)
5 Medical AI Data Analysis Market by Application
  1. 5.1 Medical AI Data Analysis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Research
  4. 5.1.3 Nursing
  5. 5.1.4 Other
  6. 5.2 Global Medical AI Data Analysis Sales Value by Application
  7. 5.2.1 Global Medical AI Data Analysis Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Medical AI Data Analysis Sales Value by Application (2021-2032)
  9. 5.2.3 Global Medical AI Data Analysis Sales Value Share by Application (2021-2032)
6 Medical AI Data Analysis Regional Value Analysis
  1. 6.1 Global Medical AI Data Analysis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical AI Data Analysis Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical AI Data Analysis Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical AI Data Analysis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical AI Data Analysis Sales Value (2021-2032)
  7. 6.3.2 North America Medical AI Data Analysis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical AI Data Analysis Sales Value (2021-2032)
  10. 6.4.2 Europe Medical AI Data Analysis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical AI Data Analysis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical AI Data Analysis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical AI Data Analysis Sales Value (2021-2032)
  16. 6.6.2 South America Medical AI Data Analysis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical AI Data Analysis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical AI Data Analysis Sales Value Share by Country, 2025 VS 2032
7 Medical AI Data Analysis Country-level Value Analysis
  1. 7.1 Global Medical AI Data Analysis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical AI Data Analysis Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical AI Data Analysis Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical AI Data Analysis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical AI Data Analysis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical AI Data Analysis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical AI Data Analysis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Tempus
  2. 8.1.1 Tempus Company Information
  3. 8.1.2 Tempus Business Overview
  4. 8.1.3 Tempus Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Tempus Medical AI Data Analysis Product Portfolio
  6. 8.1.5 Tempus Recent Developments
  7. 8.2 PathAI
  8. 8.2.1 PathAI Company Information
  9. 8.2.2 PathAI Business Overview
  10. 8.2.3 PathAI Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PathAI Medical AI Data Analysis Product Portfolio
  12. 8.2.5 PathAI Recent Developments
  13. 8.3 Paige AI
  14. 8.3.1 Paige AI Company Information
  15. 8.3.2 Paige AI Business Overview
  16. 8.3.3 Paige AI Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Paige AI Medical AI Data Analysis Product Portfolio
  18. 8.3.5 Paige AI Recent Developments
  19. 8.4 Aidoc
  20. 8.4.1 Aidoc Company Information
  21. 8.4.2 Aidoc Business Overview
  22. 8.4.3 Aidoc Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Aidoc Medical AI Data Analysis Product Portfolio
  24. 8.4.5 Aidoc Recent Developments
  25. 8.5 Viz.ai
  26. 8.5.1 Viz.ai Company Information
  27. 8.5.2 Viz.ai Business Overview
  28. 8.5.3 Viz.ai Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Viz.ai Medical AI Data Analysis Product Portfolio
  30. 8.5.5 Viz.ai Recent Developments
  31. 8.6 RapidAI
  32. 8.6.1 RapidAI Company Information
  33. 8.6.2 RapidAI Business Overview
  34. 8.6.3 RapidAI Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 RapidAI Medical AI Data Analysis Product Portfolio
  36. 8.6.5 RapidAI Recent Developments
  37. 8.7 Enlitic
  38. 8.7.1 Enlitic Company Information
  39. 8.7.2 Enlitic Business Overview
  40. 8.7.3 Enlitic Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Enlitic Medical AI Data Analysis Product Portfolio
  42. 8.7.5 Enlitic Recent Developments
  43. 8.8 Nanox AI
  44. 8.8.1 Nanox AI Company Information
  45. 8.8.2 Nanox AI Business Overview
  46. 8.8.3 Nanox AI Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nanox AI Medical AI Data Analysis Product Portfolio
  48. 8.8.5 Nanox AI Recent Developments
  49. 8.9 Lunit
  50. 8.9.1 Lunit Company Information
  51. 8.9.2 Lunit Business Overview
  52. 8.9.3 Lunit Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lunit Medical AI Data Analysis Product Portfolio
  54. 8.9.5 Lunit Recent Developments
  55. 8.10 Subtle Medical
  56. 8.10.1 Subtle Medical Company Information
  57. 8.10.2 Subtle Medical Business Overview
  58. 8.10.3 Subtle Medical Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Subtle Medical Medical AI Data Analysis Product Portfolio
  60. 8.10.5 Subtle Medical Recent Developments
  61. 8.11 Volpara Health
  62. 8.11.1 Volpara Health Company Information
  63. 8.11.2 Volpara Health Business Overview
  64. 8.11.3 Volpara Health Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Volpara Health Medical AI Data Analysis Product Portfolio
  66. 8.11.5 Volpara Health Recent Developments
  67. 8.12 icometrix
  68. 8.12.1 icometrix Company Information
  69. 8.12.2 icometrix Business Overview
  70. 8.12.3 icometrix Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 icometrix Medical AI Data Analysis Product Portfolio
  72. 8.12.5 icometrix Recent Developments
  73. 8.13 Niramai
  74. 8.13.1 Niramai Company Information
  75. 8.13.2 Niramai Business Overview
  76. 8.13.3 Niramai Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Niramai Medical AI Data Analysis Product Portfolio
  78. 8.13.5 Niramai Recent Developments
  79. 8.14 Densitas
  80. 8.14.1 Densitas Company Information
  81. 8.14.2 Densitas Business Overview
  82. 8.14.3 Densitas Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Densitas Medical AI Data Analysis Product Portfolio
  84. 8.14.5 Densitas Recent Developments
  85. 8.15 RetinAI
  86. 8.15.1 RetinAI Company Information
  87. 8.15.2 RetinAI Business Overview
  88. 8.15.3 RetinAI Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  89. 8.15.4 RetinAI Medical AI Data Analysis Product Portfolio
  90. 8.15.5 RetinAI Recent Developments
  91. 8.16 Riverain Technologies
  92. 8.16.1 Riverain Technologies Company Information
  93. 8.16.2 Riverain Technologies Business Overview
  94. 8.16.3 Riverain Technologies Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Riverain Technologies Medical AI Data Analysis Product Portfolio
  96. 8.16.5 Riverain Technologies Recent Developments
  97. 8.17 Digital Diagnostics
  98. 8.17.1 Digital Diagnostics Company Information
  99. 8.17.2 Digital Diagnostics Business Overview
  100. 8.17.3 Digital Diagnostics Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Digital Diagnostics Medical AI Data Analysis Product Portfolio
  102. 8.17.5 Digital Diagnostics Recent Developments
  103. 8.18 ANNALISE.ai
  104. 8.18.1 ANNALISE.ai Company Information
  105. 8.18.2 ANNALISE.ai Business Overview
  106. 8.18.3 ANNALISE.ai Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  107. 8.18.4 ANNALISE.ai Medical AI Data Analysis Product Portfolio
  108. 8.18.5 ANNALISE.ai Recent Developments
  109. 8.19 Imagen Technologies
  110. 8.19.1 Imagen Technologies Company Information
  111. 8.19.2 Imagen Technologies Business Overview
  112. 8.19.3 Imagen Technologies Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Imagen Technologies Medical AI Data Analysis Product Portfolio
  114. 8.19.5 Imagen Technologies Recent Developments
  115. 8.20 Ultromics
  116. 8.20.1 Ultromics Company Information
  117. 8.20.2 Ultromics Business Overview
  118. 8.20.3 Ultromics Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Ultromics Medical AI Data Analysis Product Portfolio
  120. 8.20.5 Ultromics Recent Developments
  121. 8.21 Us2.ai
  122. 8.21.1 Us2.ai Company Information
  123. 8.21.2 Us2.ai Business Overview
  124. 8.21.3 Us2.ai Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Us2.ai Medical AI Data Analysis Product Portfolio
  126. 8.21.5 Us2.ai Recent Developments
  127. 8.22 UltraSight
  128. 8.22.1 UltraSight Company Information
  129. 8.22.2 UltraSight Business Overview
  130. 8.22.3 UltraSight Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  131. 8.22.4 UltraSight Medical AI Data Analysis Product Portfolio
  132. 8.22.5 UltraSight Recent Developments
  133. 8.23 Notal Vision
  134. 8.23.1 Notal Vision Company Information
  135. 8.23.2 Notal Vision Business Overview
  136. 8.23.3 Notal Vision Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Notal Vision Medical AI Data Analysis Product Portfolio
  138. 8.23.5 Notal Vision Recent Developments
  139. 8.24 iCAD
  140. 8.24.1 iCAD Company Information
  141. 8.24.2 iCAD Business Overview
  142. 8.24.3 iCAD Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  143. 8.24.4 iCAD Medical AI Data Analysis Product Portfolio
  144. 8.24.5 iCAD Recent Developments
  145. 8.25 Medicsight
  146. 8.25.1 Medicsight Company Information
  147. 8.25.2 Medicsight Business Overview
  148. 8.25.3 Medicsight Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Medicsight Medical AI Data Analysis Product Portfolio
  150. 8.25.5 Medicsight Recent Developments
  151. 8.26 Delft Imaging
  152. 8.26.1 Delft Imaging Company Information
  153. 8.26.2 Delft Imaging Business Overview
  154. 8.26.3 Delft Imaging Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Delft Imaging Medical AI Data Analysis Product Portfolio
  156. 8.26.5 Delft Imaging Recent Developments
  157. 8.27 INFERVISION
  158. 8.27.1 INFERVISION Company Information
  159. 8.27.2 INFERVISION Business Overview
  160. 8.27.3 INFERVISION Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  161. 8.27.4 INFERVISION Medical AI Data Analysis Product Portfolio
  162. 8.27.5 INFERVISION Recent Developments
  163. 8.28 YITU Healthcare
  164. 8.28.1 YITU Healthcare Company Information
  165. 8.28.2 YITU Healthcare Business Overview
  166. 8.28.3 YITU Healthcare Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  167. 8.28.4 YITU Healthcare Medical AI Data Analysis Product Portfolio
  168. 8.28.5 YITU Healthcare Recent Developments
  169. 8.29 Shukun Technology
  170. 8.29.1 Shukun Technology Company Information
  171. 8.29.2 Shukun Technology Business Overview
  172. 8.29.3 Shukun Technology Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Shukun Technology Medical AI Data Analysis Product Portfolio
  174. 8.29.5 Shukun Technology Recent Developments
  175. 8.30 Keya Medical
  176. 8.30.1 Keya Medical Company Information
  177. 8.30.2 Keya Medical Business Overview
  178. 8.30.3 Keya Medical Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Keya Medical Medical AI Data Analysis Product Portfolio
  180. 8.30.5 Keya Medical Recent Developments
  181. 8.31 BioMind
  182. 8.31.1 BioMind Company Information
  183. 8.31.2 BioMind Business Overview
  184. 8.31.3 BioMind Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  185. 8.31.4 BioMind Medical AI Data Analysis Product Portfolio
  186. 8.31.5 BioMind Recent Developments
  187. 8.32 United Imaging
  188. 8.32.1 United Imaging Company Information
  189. 8.32.2 United Imaging Business Overview
  190. 8.32.3 United Imaging Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  191. 8.32.4 United Imaging Medical AI Data Analysis Product Portfolio
  192. 8.32.5 United Imaging Recent Developments
  193. 8.33 Merative
  194. 8.33.1 Merative Company Information
  195. 8.33.2 Merative Business Overview
  196. 8.33.3 Merative Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  197. 8.33.4 Merative Medical AI Data Analysis Product Portfolio
  198. 8.33.5 Merative Recent Developments
  199. 8.34 GE HealthCare
  200. 8.34.1 GE HealthCare Company Information
  201. 8.34.2 GE HealthCare Business Overview
  202. 8.34.3 GE HealthCare Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  203. 8.34.4 GE HealthCare Medical AI Data Analysis Product Portfolio
  204. 8.34.5 GE HealthCare Recent Developments
  205. 8.35 Siemens Healthineers
  206. 8.35.1 Siemens Healthineers Company Information
  207. 8.35.2 Siemens Healthineers Business Overview
  208. 8.35.3 Siemens Healthineers Medical AI Data Analysis Revenue and Gross Margin (2021-2026)
  209. 8.35.4 Siemens Healthineers Medical AI Data Analysis Product Portfolio
  210. 8.35.5 Siemens Healthineers Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst